330667-06-6

Upstream product

• 536-90-3 m-Anisidine 
• 5000-65-7 2-bromo-3'-methoxyacetophenone 

Downstream Products

• 1043600-48-1 4-(4-methoxyphenyl)-1-(3-methoxyphenyl)-1,3-dihydroimidazole-2-thione 
• 1043600-50-5 4-(4-methoxyphenyl)-1-(3-methoxyphenyl)-1H-imidazole 
• 62655-56-5 2-(4'-methoxy-phenyl)-6-methoxy-indole 

Relevant academic research and scientific papers

17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES

The invention relates to 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1) inhibitors, the preparation thereof and the use thereof for the treatment and prophylaxis of hormone-related, especially estrogen-related or androgen-related, diseases.

INDOLE-CONTAINING COMPOUNDS WITH ANTI-TUBULIN AND VASCULAR TARGETING ACTIVITY

Trimethoxyphenyl substituted indole ligands have been discovered which demonstrate impressive cytotoxicity as well as a remarkable ability to inhibit tubulin assembly. Such compounds as well as related derivatives are excellent clinical candidates for the